News archive

People with malignant melanoma with an inherited mutation in a certain gene are twice as likely to die of the disease, according to a new study carried out by researchers at Karolinska Institutet and Lund University in Sweden. The finding, which is published in The Journal of the National Cancer Institute, suggests that individuals with familial melanoma who have the mutation should be monitored particularly closely.

In the spring of 2016, KI researcher Tore Curstedt was nominated for a Lifetime Achievement Award by the European Patent Office for having devoted his life to Curosurf, a drug that has helped to activate the lungs of millions of preterm babies.

Charlotte Rolny and colleagues at the Department of Oncology-Pathology have discovered a new mechanism that could be the key to a new strategy to restrict breast cancer growth.